How Klebsiella bacteria build and attach their protective capsule
Control of Klebsiella capsule biosynthesis and attachment
This project explores how Klebsiella bacteria make and stick on their sugary outer capsule to help people who carry or get infections from Klebsiella.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11178602 on NIH RePORTER |
What this research studies
If you carry Klebsiella in your gut or have had Klebsiella infections, this work looks at the sugary capsule those bacteria use to protect themselves. Researchers will use bacterial cultures, genetic tools, and microscopy to see how environmental signals and metabolism switch capsule production on and off. They will map the molecules and pathways that attach the capsule to the bacterial surface and observe effects on individual cells and whole populations. The goal is to understand forces that let Klebsiella persist or evade attackers like the immune system, phages, or other microbes.
Who could benefit from this research
Good fit: People who currently carry Klebsiella in their gut, have recurrent Klebsiella infections, or are at high risk for such infections would be most relevant to this line of work.
Not a fit: People without Klebsiella colonization or unrelated health concerns are unlikely to get direct benefit from this basic laboratory research.
Why it matters
Potential benefit: Understanding capsule control could guide ways to prevent gut colonization or make Klebsiella infections easier for the immune system or therapies to clear.
How similar studies have performed: Prior laboratory studies have identified capsule genes and some attachment mechanisms, but linking environmental signals and bacterial metabolism to capsule attachment is a newer direction with limited clinical translation so far.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Mike, Laura Anzaldi — University of Pittsburgh at Pittsburgh
- Study coordinator: Mike, Laura Anzaldi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.